The interaction of thrombin with blood platelets

References

• Kirkegaard S. Danish Philosopher, 1813–1855, 1843; Journals and Papers 1:1030 (PAP IV.A 164) n.d.; as cited in The essential Kirkegaard, Hong HV, Hong EH, editors. Princeton, NJ: Princeton University Press; 2000.
   Google Scholar
• Mohammed SF, Whitworth C, Chuang HY, Lundblad RL, Mason RG. Multiple active forms of thrombin: Binding to platelets and effects on platelet function. Proc Natl Acad Sci USA 1976;73:1660–1663.
   PubMedGoogle Scholar
• Workman EF Jr, White GC II, Lundblad RL. High affinity binding of thrombin to platelets. Inhibition by tetranitromethane and heparin. Biochem Biophys Res Commun 1977;75:925–932.
   PubMedGoogle Scholar
• Workman GF Jr, White GC II, Lundblad RL. Structure function relationships in the interaction of a-thrombin with blood platelets. J Biol Chem 1977;252:7118–7123.
   PubMedGoogle Scholar
• White GC II, Workman GF Jr, Lundblad RL. The binding of thrombin to thrombasthenic platelets. J Lab Clin Med 1978;91:76–82.
   PubMedGoogle Scholar
• Wu, H-F, White GC II, Workman EF Jr, Jenzano JW, Lundblad RL. Affinity chromatography of platelets on immobilized thrombin: Retention of catalytic activity by platelet-bound thrombin. Thromb Res 1992;67:419–427.
   PubMedGoogle Scholar
• Rao GHR. Platelet physiology and pharmacology: An over- view. In: Rao GHR, editor. Handbook of platelet physiology and pharmacology. Boston: Kluwer; 1986. pp 1–24.
   Google Scholar
• Kroll MH, Sullivan R. Mechanism of platelet activation. In: Loscalzo J, Shafer AI, editors. Thrombosis and hemor- rhage, 2nd ed. Baltimore, MD: Williams and Wilkins; 1998. pp 261–291.
   Google Scholar
• Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002.
   Google Scholar
• Clemetson KJ. Platelet receptors. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 65–84.
   Google Scholar
• Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001;86:178–188.
   PubMed Web of Science ®Google Scholar
• Plow EF Ginsberg MH. The molecular basis for platelet function. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen BJ, Silberstein LE, McGlave P, editors. Hematology. Basic principles and clinical practice. 3rd ed. New York: Churchill Livingstone; 2000. pp 1741–1752.
   Google Scholar
• Marcus AJ. Platelets and their disorders. In: Ratnoff OD, Forbes CD, editors. Disorders of hemostasis. 3rd ed. Philadelphia, PA: W.B. Saunders; 1996. pp 79–137.
   Google Scholar
• Packham, MA, Rand ML, Kinlough-Rathbone RL. Aggregation. In: Gresele P, Page C, Foster V, Vermylen J, editors. Platelets in thrombotic and non-thrombotic disesase. Pathology, pharmacology and therapeutics. Cambridge, UK: Cambridge University Press; 2002. pp 338–356.
   Google Scholar
• Brass LF. The molecular basis for platelet activation. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, editors. Hematology. Basic principles and clinical practice. 3rd ed. New York: Churchill Livingston; 2000. pp 1753–1770.
   Google Scholar
• Marcus AJ, Safier LB. Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombo- sis. FASEB J 1993;7:516–522.
   PubMed Web of Science ®Google Scholar
• Hoylaerts MF, Oury C, Toth-Zamboki E, Vermylen J. ADP receptors platelet activation and aggregation. Platelets 2000;11:307–309.
   PubMed Web of Science ®Google Scholar
• Kroll MH, Sullivan R. Mechanisms of platelet activation. In: Loscalzo J, Shafer AJ, editors. Thrombosis and hemostasis. 2nd ed. Baltimore, MD: Williams and Wilkins; 1998. pp 261–291.
   Google Scholar
• Fukami MH, Holmsen H, Kowalska MA, Niewiarkowski S. Platelet secretion. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis. Basic principles and clinical practice. 4th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001. pp 561–573.
   Google Scholar
• Heemskerk JWM Siljander PRM Bevers EM Farndale RW Lindhout T. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets 2000;11:301–306.
   Google Scholar
• Hempker HC. Platelet procoagulant activities: The amplifica- tion loops between platelets and the plasmatic clotting system. In: Gresele P, Page C, Foster V, Vermylen J, editors. Platelets in thrombotic and non-thrombotic disease. Pathology, pharmacology and therapeutics. Cambridge, UK: Cambridge University Press; 2002. pp 381–392.
   Google Scholar
• Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88:186–193.
   PubMed Web of Science ®Google Scholar
• Gresde P, Page CP, Fuster V, Vermylen J. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology, and therapeutics. Cambridge, UK: Cambridge University Press; 2002.
   Google Scholar
• Wright JH, Minot GR. The viscous metamorphosis of the blood platelets. J Exp Med 1917;26:395–409.
   PubMedGoogle Scholar
• Wright HP. The adhesiveness of blood platelets in normal subjects with varying concentrations of anti-coagulants. J Pathol Bacteriol 1941;53:255–262.
   Google Scholar
• Wright HP. Changes in the adhesiveness of blood platelets following parturition or surgical operations. J Pathol Bacteriol 1942;54:461–468.
   Google Scholar
• Wright HP. Adhesiveness of platelets in haemophilia. Lancet 1946;250(i):306–307.
   Google Scholar
• Tocantins LM. Platelets and the structure of and physical properties of blood clots. Am J Physiol 1936;114:709–715.
   Google Scholar
• Pinniger JL, Prunty FTG. Some observations on the blood-clotting mechanism. The role of fibrinogen and platelets with reference to a case of congenital hypofibrino- genaemia. Br J Exp Pathol 1946;27:200–210.
   Google Scholar
• Alexander B, Goldstein R, Rich L, Le Bulloc’h AG, Diamond LK, Borges W. Congenital afibrinogenemia. A study of some basic aspects of coagulation. Blood 1954;9:843–865.
   Google Scholar
• Schmid HJ, Jackson DP, Conley CL. Mechanism of action of thrombin on platelets. J Clin Invest 1962;41:543–553.
   PubMedGoogle Scholar
• Booyce FM, Rafelson ME Jr. Regulation and mechanism of platelet aggregation. Ann NY Acad Sci 1972;201:37–60.
   PubMedGoogle Scholar
• Mustard JF, Packham MA. Factors influencing platelet function, adhesion, release, and aggregation. Pharmacol Rev 1970;22:97–197.
   PubMed Web of Science ®Google Scholar
• Coller BS. A brief and selective history of ideas about platelets in health and disease. In: Michaelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. Foreword, p xxix–xliii.
   Google Scholar
• Mustard JF, Kinlough-Rathbone RL, Packham MA. History of platelets. In: Gresde P, Page CP, Fuster V, Vermylen J, editors. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology, and therapeutics. Cambridge, UK: Cambridge University Press; 2002.
   Google Scholar
• Detwiler TC, Feinman RD. Kinetics of thrombin release of Ca(II) by platelets. Biochemistry 1973;12:282–289.
   PubMed Web of Science ®Google Scholar
• Ganguly P. Binding of thrombin to human platelets. Nature 1974;247:306–307.
   PubMedGoogle Scholar
• Tollefsen DM, Feagler JR, Majerus PW. The binding of thrombin to the surface of human platelets. J Biol Chem 1974;249:2646–2651.
   PubMedGoogle Scholar
• Tollefsen DM, Majerus PW. Evidence for a single class of thrombin-binding sites on human platelets. Biochemistry 1976;15:2144–2149.
   PubMedGoogle Scholar
• Tollefson DM, Jackson CM, Majerus PW. Binding of the products of prothrombin activation to human platelets. J Clin Invest 1975;56:241–245.
   PubMedGoogle Scholar
• Phillips DR. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin. Thromb Diath Haemmorh 1974; 32:207–215.
   Google Scholar
• Phillips DR, Agin PP. Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranes. Biochim Biophys Acta 1974;352:218–227.
   PubMed Web of Science ®Google Scholar
• Martin BM, Feinman RD, Detwiler TC. Platelet stimula- tion by thrombin and other proteases. Biochemistry 1975;14:1308–1314.
   PubMedGoogle Scholar
• Ganguly P. Interaction of thrombin with human platelets. Br J Haematol 1975;29:617–626.
   PubMedGoogle Scholar
• Shuman MA, Majerus PW. The perturbation of thrombin binding to human platelets by anions. J Clin Invest 1975;56:945–950.
   PubMedGoogle Scholar
• Martin BM, Wasiewski WW, Fenton JW, Detwiler TC. Equilibrium binding of thrombin to platelets. Biochemistry 1976;15:4886–4893.
   PubMedGoogle Scholar
• Shuman MA, Tollefson DM, Majerus PW. The binding of human and bovine thrombin to human platelets. Blood 1976;47:43–54.
   PubMedGoogle Scholar
• Ganguly P, Sonnichsen WJ. Binding of thrombin to human platelets and its possible significance. Br J Haematol 1976;34:291–301.
   PubMedGoogle Scholar
• Chuang, HY, Mohammad SF, Crowther PE, Mason RG. A concise method for study of the binding of thrombin to human platelets. Res Commun Chem Pathol Pharmacol 1977;18:291–301.
   PubMedGoogle Scholar
• Tam SW, Detwiler TC. Binding of thrombin to platelet plasma membranes. Biochim Biophys Acta 1978;543:194–201.
   PubMedGoogle Scholar
• Ganguly P, Gould NL Thrombin receptors of human platelets: thrombin binding and antithrombin properties of glycoprotein I. Br J Haematol 1979;42:137–145.
   PubMed Web of Science ®Google Scholar
• Tam SW, Fenton JW 2nd, Detwiler TC. Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem 1979;254:8723–8725.
   Google Scholar
• Rotoli B, Miletich JP, Majerus PW. The relation of conductivity to the binding of thrombin to human platelets. Thromb Res 1978;13:1103–1109.
   PubMedGoogle Scholar
• Rotoli B, Majerus PW. Plasma antithrombins and thrombin binding to platelets in plasma. Haematologica 1979; 64:537–551.
   PubMedGoogle Scholar
• White GC, Lundblad RL, Griffith MJ. Structure–function relations in platelet–thrombin reactions. Inhibition of platelet–thrombin interactions by lysine modification. J Biol Chem 1981;256:1763–1766.
   Google Scholar
• Griffith MJ. Covalent modification of human a-thrombin with pyridoxal 50-phosphate. Effect of phosphopyridoxylation on the interaction of thrombin with heparin. J Biol Chem 1979;254:3401–3406.
   Google Scholar
• Klotz IM. Number of receptor sites from Scatchard graphs: Facts and fantasies. Science 1982;217:1247–1249.
   PubMed Web of Science ®Google Scholar
• Klotz IM, Huntson DL. Mathematic models for ligand- binding. Real sites, ghost sites. J Biol Chem 1984;259:10060–10062.
   Google Scholar
• Klotz IM. Estimation of number of receptor sites: A misconception. Biopharm Drug Dispos 1985;6:105–106.
   PubMedGoogle Scholar
• Rodbard D. Negative cooperativity: A positive finding? Amer J Physiol 1979;237:E203–E205.
   PubMedGoogle Scholar
• Faguet CB. Leukoagglutinin binding to human lymphocytes. Experimental support for negative cooperativity. Am J Physiol 1979;237:E207–E213.
   Google Scholar
• Sackett DL, Soroff HA. The multiple origins of coopera- tivity in binding to multi-site lattices. FEBS Lett 1996; 397:1–6.
   PubMedGoogle Scholar
• Sidhu P, Sutherland SB, Ganguly P. Interaction of thrombin with mammalian platelets. Am J Physiol 1979;237:H353–H358.
   Google Scholar
• Danishefsky KJ, Alexander RJ, Detwiler TC. Formation of a stable complex of thrombin and the secreted platelet glycoprotein G (thrombin-sensitive protein, thrombospon- din) by thiol-disulfide exchange. Biochemistry 1984; 23:4984–4990.
   PubMed Web of Science ®Google Scholar
• Larsen NE, Simons ER. Preparation and application of a photoreactive thrombin analogue: Binding to human platelets. Biochemistry 1981;20:4141–4147.
   PubMedGoogle Scholar
• Shuman MA, Issacs JD, Maerowitz T, Savien N, Gospodarowicz D, Glenn K, Cunningham D, Fenton JW II. Endothelial cells and platelet binding sites for thrombin. Ann NY Acad Sci 1981;370:57–66.
   PubMedGoogle Scholar
• Gronke RS, Curry TK, Baker JB. Formation of protease nexin-thrombin complexes on the platelet surface. J Cell Biochem 1986;32:201–206.
   PubMedGoogle Scholar
• Gronke RS, Bergman BL, Baker JB. Thrombin interaction with platelets. Influence of a platelet protease nexin. J Biol Chem 1987;262:3030–3036.
   PubMedGoogle Scholar
• Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Platelet protease nexin-2/amyloid beta-protein precursor. Possible pathologic and physiologic function. Ann NY Acad Sci 1991;60:140–144.
   Google Scholar
• Davey MB, Lu¨ scher EF. Action of thrombin and other coagulation proteases on blood platelets. Nature 1967;26:857–859.
   Google Scholar
• Baenziger NL, Brodie GN, Majerus PW. A thrombin- sensitive protein on human platelet membranes. Proc Natl Acad Sci USA 1971;68:240–243.
   PubMed Web of Science ®Google Scholar
• Phillips DR, Agin PP. Thrombin-induced changes in the surface structure of the human platelet plasma membrane. Ser Haematol 1973;6:292–310.
   PubMedGoogle Scholar
• Berndt MC, Phillips DR. Interaction of thrombin with platelets: Purification of the thrombin substrate. Ann NY Acad Sci 1981;370:87–95.
   PubMedGoogle Scholar
• Simons ER, Davies TA, Greenberg SM, Larsen NE. Thrombin receptors on human platelets. Methods Enzymol 1992;215:155–177.
   PubMedGoogle Scholar
• Plapp BV. Site-directed mutagenesis: A tool for studying enzyme catalysis. Methods Enzymol 1995;249:91–119.
   PubMedGoogle Scholar
• Greco NJ, Tannen TE Jr, Tandon NN, Jamieson GA. PPACK-thrombin inhibits thrombin-induced platelet aggre- gation and cytoplasmic acidification but does inhibit platelet shape change. Blood 1990;75:1989–1990.
   PubMedGoogle Scholar
• Tandon NN, Ordinas A, Jamieson GA. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin. Biochim Biophys Acta 1982;719:388–395.
   PubMedGoogle Scholar
• Okamura T, Jamieson GA. Platelet glycocalicin: A single receptor of platelet aggregation incuded by thrombin and ristocetin. Thromb Res 1976;8:701–708.
   PubMedGoogle Scholar
• Adam F, Guillin M-C, Jandrot-Perrus M. Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin. Europ J Biochem 2003;270:2959–2970.
   Google Scholar
• Ganguly P, Gould NL. Thrombin receptors of human platelets: Thrombin binding and antithrombin properties of glycoprotein I. Br J Haematol 1979;42:137–145.
   PubMed Web of Science ®Google Scholar
• Jamieson GA, Jung SM, Ordinas A. Factors affecting the high- affinity binding of thrombin to platelets. Ann NY Acad Sci 1981;370:96–100.
   PubMedGoogle Scholar
• Okamura T, Jamieson GA. Platelet glycocalicin. I. Orientation of glycoproteins in the human platelet surface. J Biol Chem 1976;251:5944–5949.
   Google Scholar
• Okamura T, Jamieson GA. Platelet glycocalicin. II. Purification and characterization. J Biol Chem 1976; 251:5950–5955.
   Google Scholar
• Phillips DR. Effect of thrombin on the exposed polypeptides and glycoproteins of the human platelet membrane. Biochemistry 1972;11:4582–4588.
   PubMed Web of Science ®Google Scholar
• Nachman RL, Hubbard A, Ferris B. Iodination of the human platelet membrane. Studies on the major surface glycoprotein. J Biol Chem 1973;281:2928–2936.
   Google Scholar
• Loscalzo J, Handin RI. Platelet glycocalicin, Methods Enzymol 1992;215:289–294.
   PubMedGoogle Scholar
• Jamieson GA, Okamura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978;61:861–864.
   PubMed Web of Science ®Google Scholar
• Cooper HA, Bennett WP, White GC II, et al. Hydrolysis of human platelet membrane proteins with a Serratia marcescens metalloprotease: Effect on response to thrombin and von Willebrand factor. Proc Natl Acad Sci USA 1982; 79:1433–1437.
   PubMedGoogle Scholar
• Harmon JT, Jamieson GA. Platelet-activation by thrombin in the absence of the high-affinity thrombin receptor. Biochemistry 1988;27:2151–2157.
   PubMedGoogle Scholar
• Jamieson GA, Jung SM, Ordinas A. Factors affecting the high-affinity binding of thrombin to platelets. Ann NY Acad Sci 1981;370:96–100.
   PubMedGoogle Scholar
• Moroi M, Goetze A, Dubay E, Wu C, Hasitz M, Jamieson GA. Isolation of platelet glycocalicin by affinity chromatography on thrombin-Sepharose. Thromb Res 1982; 28:103–114.
   PubMedGoogle Scholar
• Okamura T, Hasitz M, Jamieson GA. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem 1978;253:3435–3443.
   Google Scholar
• Tandon N, Harmon JT, Rodbard D, Jamieson GA. Thrombin receptors define responsiveness of cholesterol- modified platelets. J Biol Chem 1983;258:11840–11845.
   PubMed Web of Science ®Google Scholar
• Harmon JT, Jamieson GA. Thrombin binds to a high-affinity approximately 900,000-dalton site on human platelets. Biochemistry 1985;24:58–64.
   PubMedGoogle Scholar
• Harmon JT, Jamieson GA. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 1986;261:13224–13229.
   Google Scholar
• Harmon JT, Jamieson GA. Activation of platelets by a-thrombin is a receptor-mediated event. D-Phenylalanyl- L-prolyl-L-arginine chloromethyl ketone-thrombin but not Na-tosyl-L-lysine chloromethyl ketone-thrombin binds to the high affinity thrombin receptor. J Biol Chem 1986;261:15928–15933.
   Google Scholar
• Cray CH, Koeppe JR, Bergqvist S, Komives EA. Allosteric changes in solvent accessibility observed in thrombin upon active site occupancy. Biochemistry 2004;43:5246–5255.
   PubMedGoogle Scholar
• Harmon JT, Jamieson GA. Platelet activation by a-thrombin is a receptor mediated event. Ann NY Acad Sci 1986;485:387–395.
   PubMedGoogle Scholar
• De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001;276:4692–4698.
   PubMed Web of Science ®Google Scholar
• Celikel R, McClintock RA, Roberts JR, Mendolicchio GL, Ware J, Varughese KT, Ruggeri ZM Modulation of a-thrombin by distinct interactions with platelet glycoprotein Iba. Science 2003;301:218–221.
   PubMedGoogle Scholar
• Dumas JJ, Kumar R, Seetra J, Somers WS, Mosyak L. Crystal structure of the GpIa–thrombin complex essential for platelet aggregation. Science 2003;301:222–226.
   PubMedGoogle Scholar
• Jamieson GA, Tandon NN, Greco NJ. Human platelet thrombin receptors and the two receptor model for platelet activation. In: Rao GHR, editor. Handbook of platelet physiology and pharmacology. Boston, MA: Kluwer; 1999, pp 21–37.
   Google Scholar
• Yamamoto N, Greco NJ, Barnard MR, Tonoue K, Yamazaki M, Jamieson GA, Michelsen AD. Glycoprotein Ib (GPIb)-dependent and independent pathways of thrombin-induced platelet activation. Blood 1991;77:1740–1748.
   PubMed Web of Science ®Google Scholar
• Greco NJ, James GD, Tandon NN, Kornhauser R, Jackson B, Jamieson GA. Differentiation of the two forms of GpIb functioning as receptors for a-thrombin and von Willebrand protein factor: Ca2þ responses of protease-treated human platelets activation with a-throm- n and the tethered ligand peptide. Biochemistry 1996; 35:915–921.
   PubMedGoogle Scholar
• Wicki AN, Clemetson JM, Steiner B, Schnippering W, Clemetson KJ. Isolation and characterization of glycoprotein Ib. Methods Enzymol 1992;215:276–288.
   PubMedGoogle Scholar
• Lo´pez JA. The platelet glycoprotein Ib-IX complex. Blood Coag Fibrinolysis 1994;5:97–100.
   Google Scholar
• Moddenman PW, Admiroal LG, Sonneberg A, von dem Berne AEGKr. Glycoproteins V and Ib-IX form a noncovalent bond in the platelet membrane. J Biol Chem 1992;267:363–369.
   Google Scholar
• Lo´pez JA, Berndt MC. The GpIb-IX-V complex. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 85–104.
   Google Scholar
• Jenkins CSP, Phillips DR, Clemetson KJ, Meyer D, Larrieu M-J, Lu¨ scher EF. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand’s disease. J Clin Invest 1976;57:112–124.
   Google Scholar
• Rivera J, Lozano ML, Corral J, Gonzalez-Conejero R, Martinez C, Vicente V. Platelet GP Ib/IX/V complex: Physiological role. J Physiol Biochem 2000;56:355–365.
   PubMedGoogle Scholar
• Andrews RK, Gardiner EE, Shen Y, Wisstock JC, Berndt MC. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003;35:1170–1174.
   PubMed Web of Science ®Google Scholar
• Hourdille´ P, Heilmann E, Cambrie´ R, Winckler J, Clemetson KJ, Nurden AT. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1996;76:1503–1513.
   Google Scholar
• Plow EF, D’souza SE, Ginsberg MH Ligand binding to GpIIb-IIIa: A status report. Semin Thromb Haemost 1997;18:324–331.
   Google Scholar
• Hato T, Ginsberg MH, Shattil SJ. Integrin aIIbf33. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 105–116.
   Google Scholar
• Mosher DF, Vaheri A, Choate JJ, Gahmberg CG. Action of thrombin on surface glycoproteins of human platelets. Blood 1979;53:437–445.
   PubMedGoogle Scholar
• Berndt MC, Phillips DR. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem 1981;256:59–65.
   PubMedGoogle Scholar
• Dong J-F, Sae-Tung G, Lo´ pez JA. Role of glycoprotein V in the function of the platelet high-affinity thrombin-binding site. Blood 1997;85:4355–4363.
   Google Scholar
• Hoffman BB, Lefkowitz RJ. Agonist interactions with alpha-adrenergic recptors. J Cardiovascular Pharmacol 1982;4(Suppl 1):S14–S18.
   Google Scholar
• Gilman AG. G proteins and dual control of adenyl cyclase. Cell 1984;36:577–579.
   PubMed Web of Science ®Google Scholar
• Lefkowitz FJ, Caron MG. Adrenergic receptors: Molecular mechanisms of clinically relevant regulation. Clin Res 1985;33:395–406.
   PubMedGoogle Scholar
• Gilman AG. G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987;56:615–649.
   PubMed Web of Science ®Google Scholar
• Emala CW, Schwindinger WF, Wand GS, Levine MA. Signal-transducing G protein: Basic and clinical implications. Prog Nucleic Acid Res Mol Biol 1994; 47:81–111.
   PubMedGoogle Scholar
• Neer EJ. G proteins: Critical control points for transmem- brane signals. Protein Sci 1994;3:3–14.
   PubMedGoogle Scholar
• Brass LF, Loposata M, Banga HS, Rittenhouse SE. Regulation of the phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by a pertussis toxin-sensitive guanine nucleotide-binding protein. Evaluation of its con- tribution to platelet activation and comparisons with the adenylate cyclase inhibitory protein, Gi. J Biol Chem 1986;261:16838–16847.
   Google Scholar
• Berndt JC, Gregory C, Dowden G, Castaldi PA. Thrombin interaction with the platelet membrane. Ann NY Acad Sci 1986;485:374–386.
   PubMedGoogle Scholar
• Dohlman H, Thorner J, Caron M, et al. Model systems for the study of seven-transmembrane segment receptors. Annu Rev Biochem 1992;60:651–688.
   Google Scholar
• Vu T-KH, Hung DT, Wheaton WI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057–1068.
   PubMed Web of Science ®Google Scholar
• Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq J-P, Pouysse´gur J, van Obberghen-Schilling E. c-DNA Cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2þ mobilization, FEBS Lett 1991;288:123–128.
   Google Scholar
• Hung DT, Wong YH, Vu T-KH, Coughlin SR. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate both phosphoinositide hydrolysis and inhibit adenyl cyclase. J Biol Chem 1992; 353:20831–20834.
   Google Scholar
• Coughlin SR. How thrombin ‘talks’ to cells. Molecular mechanisms and roles in vivo. Arterioscler Thromb Vasc Biol 1998;18:514–518.
   PubMedGoogle Scholar
• Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999;103:879–887.
   PubMed Web of Science ®Google Scholar
• Schmidlin F, Bunnett NW. Protease-activated receptors: How proteases signal to cells. Curr Opin Pharmacol 2001;6:575–582.
   Google Scholar
• Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002;54:203–217.
   Google Scholar
• Trejo J. Protease-activated receptors: New concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther 2003;307:437–442.
   PubMed Web of Science ®Google Scholar
• Hollenberg MD. Proteinase-mediated signaling: Proteinase activated receptors (PARs) and much more. Life Sci 2003;7:237–246.
   Google Scholar
• Noorbakhsh F, Vergalle N, Hollenberg MD, Power C. Proteinase-activated receptors in the nervous system. Nat Rev Neurosci 2003;4:981–990.
   PubMed Web of Science ®Google Scholar
• Ossouskaya VS, Bunnett NW. Protease-activated receptors: Relation to physiology and disease. Physiol Rev 2004;84:579–621.
   PubMedGoogle Scholar
• White CJ. Growth factor alphabet soup N for what ails you. J Invasive Cardiol 1999;11:618–619.
   PubMedGoogle Scholar
• Walling H. When will the MEK inherit the ERK? Acronym alphabet soup. Trends Pharmacol Sci 2001;22:14.
   PubMedGoogle Scholar
• Charkowski AO. Making sense of alphabet soup... Physiol Genomics 2004;16:180–181.
   PubMedGoogle Scholar
• Blackhart BD, Cuenco G, Toda T, Scarborough RM, Wolf DL, Ramakrishnan V. The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptor. Growth Factors 1994;11:17–18.
   PubMed Web of Science ®Google Scholar
• Ishii K, Gerszten R, Zheng YW, Welsh JB, Turek CW, Couglin SR. Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and the role of P3 aspartate. J Biol Chem 1995;270:16435–16440.
   Google Scholar
• Myles T, Le Bonniac BF, Stone SR. The dual role of thrombin’s anion binding exosite-1 in the recognition and cleavage of the protease-activated receptor. Eur J Biochem 2001;268:70–77.
   PubMedGoogle Scholar
• Fox MT, Greer B, Lawson J, Healy A, Harriott P. Kinetic analysis of the cleavage of human protease-activated receptor 1/2/3 and 4 using quenched-fluorescence peptide substrates. Protein Peptide Lett 2002;9:287–297.
   Google Scholar
• Jacques SL, Kuliopulos A. Protease-activated receptor-4 uses dual pralines and an anionic retention motif for thrombin recognition and cleavage. Biochem J 2003;376:733–740.
   PubMedGoogle Scholar
• Griffith MJ, Lundblad RL, Dissociation of antithrombin III- thrombin complex. Formation of active and inactive antithrombin III. Biochemistry 1981;20:105–110.
   Google Scholar
• Jacques SL, LeMasurier M, Sheridan PJ, Seeley SK, Kuliopulos A. Substrate-assisted catalysis of the PAR1 thrombin receptor. Enhancement of macromolecular asso- ciation and cleavage. J Biol Chem 2000;275:40671–40678.
   Google Scholar
• Ma L, Perini R, McKnight W, Dicay M, Klein A, Hollenberg MD, Wallace JL. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platetets. Proc Natl Acad Sci USA 2005; 102:216–220.
   PubMed Web of Science ®Google Scholar
• Vinazzer H. Hereditary and acquired antithrombin deficiency. Semin Thromb Hemost 1999;25:257–263.
   PubMed Web of Science ®Google Scholar
• Liu CY, Nossel HL, Kaplan KA. The binding of thrombin by fibrin. J Biol Chem 1979;254:10421–10425.
   PubMedGoogle Scholar
• Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003;89:9–12.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Chao FC, Tullis JL. Antithrombin activity of intact human platelets. Thromb Diath Haemmorh 1975; 34:115–126.
   PubMedGoogle Scholar
• Watanabe K, Chao FC, Tullis JL. Platelet antithrombins: Role of thrombin binding and the release of platelet fibrinogen. Br J Haematol 1977;35:123–133.
   PubMedGoogle Scholar
• Tullis JL, Watanabe K. Platelet antithrombin deficiency. A new clinical entity. Am J Med 1978;65:472–478.
   Google Scholar
• Tullis JL, Honegger H, Fleishaker O, Hewitt L, Kenney D, Chao FC. Thrombin inhibition by malignant and normal cells. A cell-bound antithrombin effect. Cancer 1981;48:1177–1182.
   Google Scholar
• Sloand EM, Kenney DM, Chao FC, Lauder J, Tullis JL. Platelet antithrombin defect in malignancy: Platelet protein alterations. Blood 1987;69:479–485.
   PubMedGoogle Scholar
• Czapek EE, Kwaan HC. Platelet antithrombin activity. Thromb Res 1980;18:623–627.
   PubMedGoogle Scholar
• Kim BK, Steiner M, Baldini MG. Antithrombin III binds to human platelets. Biochem Biophys Res Commun 1980; 97:1227–1232.
   PubMedGoogle Scholar
• Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981;78:2049–2052.
   Google Scholar
• Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vascular surface. FASEB J 1995;9:946–955.
   PubMed Web of Science ®Google Scholar
• Slungaard, A. Platelet factor 4 modulation of the thrombomodulin-protein C system. Crit Care Med 2004;32(Suppl 5):S331–335.
   Google Scholar
• Clemetson KJ, Clemetson JN. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thomb Hemost 1995;21:130–136.
   PubMed Web of Science ®Google Scholar
• Grand RJA, Turnell AS, Grabham PW. Cellular conse- quences of thrombin-receptor activation. Biochem J 1996; 313:353–368.
   PubMed Web of Science ®Google Scholar
• Algermissen B, Sitzmann J, Nu¨ rnberg W, Laubscher JC, Henz RM, Bauer F. Distribution and potential biological function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 2000;292:488–495.
   Google Scholar
• Vliagoftis H. Thrombin induces mast cell adhesion to fibronectin: Evidence for involvement of protease-activated receptor-1. J Immunol 2002;169:4551–4558.
   PubMed Web of Science ®Google Scholar
• Greenberg DL, Mize GJ, Takayama TK. Protease- activated receptor mediated RhoA signaling and cytoske- letal reorganization in LNCaP cells. Biochemistry 2003; 42:702–709.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Junker U, Schilli-Westermann M, Klotzer C, Scheele J, Junker K. Meizothrombin, an intermediate of prothrombin cleavage potently activates renal carcinoma cells by interaction with PAR-type thrombin receptors. Oncol Rep 2003;10:493–496.
   PubMedGoogle Scholar
• Brass LE, Molina M, O’Brien PJ, Kahn M. Platelet receptors for thrombin. In: Gresele P, Page CP, Fuster V, Vermylen J, editors. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology, and therapeutics. Cambridge, UK: Cambridge University Press; 2002. pp 113–126.
   Google Scholar
• Tolentino AR, Bahou WF. Thrombin receptors. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 117–138.
   Google Scholar
• Jandrot-Perrus M, Clemetson KJ, Huisse MG, Guillin MC. Thrombin interaction with platelet glycoprotein Ib: Effect of glycocalicin on thrombin specificity. Blood 1992; 80:2781–2786.
   PubMedGoogle Scholar
• De Merco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha- thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 1994;269:6478–6484.
   PubMedGoogle Scholar
• Jandrot-Perrus M, Bouton MC, Lanza F, Guillin MC. Thrombin interaction with platelet glycoprotein Ib. Semin Thromb Hemost 1996;22:151–156.
   PubMedGoogle Scholar
• De Candia E, De Cristofaro R, De Marco L, Mazzulcalo M, Picozzi M, Landolfi R. Thrombin interaction with platelet GpIB: Role of the heparin binding domain. Thromb Haemost 1997;77:735–740.
   PubMedGoogle Scholar
• Bradford HN, Deal Cadeno RA, Kunapuli SP, Dong JF, Lope´z JA, Colman RW. Human kininogen regulates thrombin binding to platelets through glycoprotein Ib-IX-V complex. Blood 1997;90:1508–1515.
   PubMedGoogle Scholar
• Mazzucato M, Marco LD, Masotti A, Prodallo P, Bahou WF, Ruggeri ZM. Characterization of the initial alpha- thrombin interaction with glycoprotein IB alpha in relation to platelet activation. J Biol Chem. 1998;273:1880–1887.
   PubMedGoogle Scholar
• de Cristofaro R, de Candio E, Crace G, Murosetti R, Landolfi R. Binding of human alpha-thrombin to platelet GpIb: Energetics and functional effects. Biochem J 1998;332:643–650.
   PubMedGoogle Scholar
• Bouton MC, Thurieau C, Guillin MC, Jandrot-Perrus M. Characteristics of the interaction between thrombin exosite I and the sequence 269–287 of platelet glycoprotein Ibalpha. Thromb Haemost 1998;80:310–315.
   PubMedGoogle Scholar
• De Cristofaro R, De Candio E, Rutella S, Weitz JI. The asp(272)-glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha- thrombin and protects the enzyme from the heparin- catalyzed inhibition by antithrombin III. J Biol Chem 2000;275:3887–3895.
   PubMedGoogle Scholar
• Dorman D, Clemetson KJ, Kehrel BE. The GpIb thrombin binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000;96:2467–2478.
   Google Scholar
• De Cristofaro R, De Fillippi V. Interaction of the 268–282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochem J 2003;373:593–601.
   PubMedGoogle Scholar
• De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001;276:4692–4698.
   PubMed Web of Science ®Google Scholar
• Brass LE. Thrombin and platelet activation. Chest 2003; 124:18S–25S.
   Google Scholar
• Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, Housman DE, Graybiel AM. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004;10:982–986.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 2001; 98:1823–1828.
   PubMed Web of Science ®Google Scholar
• Souslau G, Class P, Morgan DA, Foster C, Lord ST, Marchese P, Ruggeri ZM. Unique pathway of thrombin- induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001;276:21173–21183.
   PubMedGoogle Scholar
• Kaiser-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ. Signaling through GPIb-IX-V activates aIIbf33 independently of other receptors. Blood 2004;103:3403–3411.
   PubMedGoogle Scholar
• Lova P, Campus F, Lombardi R, Cattaneo M, Sinigaglia F, Balduini C, Torti M. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the Gi-independent activation of platelet Rap1B by thrombin. J Biol Chem 2004;279:25299–25306.
   PubMed Web of Science ®Google Scholar
• Jarvis GE, Atkinson BT, Frampton J, Watson SP. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb. Br J Pharmacol 2003;138:574–583.
   PubMed Web of Science ®Google Scholar